Mapping prenatal predictors and neurobehavioral outcomes of an epigenetic marker of neonatal inflammation - A longitudinal population-based study.

ABSTRACT:

Background

DNA methylation levels at specific sites can be used to proxy C-reactive protein (CRP) levels, providing a potentially more stable and accurate indicator of sustained inflammation and associated health risk. However, its use has been primarily limited to adults or preterm infants, and little is known about determinants for - or offspring outcomes of - elevated levels of this epigenetic proxy in cord blood. The aim of this study was to comprehensively map prenatal predictors and long-term neurobehavioral outcomes of neonatal inflammation, as assessed with an epigenetic proxy of inflammation in cord blood, in the general pediatric population.

Methods

Our study was embedded in the prospective population-based Generation R Study (n = 2,394). We created a methylation p

SUBMITTER: Suleri A 

PROVIDER: S-EPMC11784988 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature